Patent · US Active

Sulfonylamino-acetic acid derivatives

US7435815B2 · kind B2 · utility

9Cited by

0References

14Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Martine Clozel · Binningen, CH
Walter Fischli · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thierry Sifferlen · Allschwil, CH
Thomas Weller · Binningen, CH

Key dates

Filing date	May 31, 2007
Grant date	Oct 14, 2008
Priority date	—
Expiry date	May 31, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel sulfonylamino-acetic acid derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of such compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.